Tecrea Limited
Private Limited Company · London
ActiveUnited KingdomIncorporated 2012Private Limited Company
Documents & history
Available account evidence and business events. This is not a complete filing history or document library.
Accounts to 2025-03-31
IXBRL · 121 source facts · 20 selected values
Validation findingsXBRL valid
Accounts to 2025-03-31
IXBRL · 121 source facts · 20 selected values
Validation findings
XBRL valid
- Reporting period
- 2024-04-01 to 2025-03-31
- Extraction status
- complete
- Numeric facts
- 79
- Documents processed
- 1
- XBRL standards validation
- valid
- Filing-profile validation
- invalid
- Parser
- arelle 2.44.4
- Taxonomy
- FRS-102-2025-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_2603_07966622_20250331
- Source archive
- Accounts_Monthly_Data-March2026.zip
Extraction findings: filing rules invalid. These describe source processing, not an audit opinion on the company.
Accounts to 2024-03-31
IXBRL · 122 source facts · 20 selected values
Validation findingsXBRL valid
Accounts to 2024-03-31
IXBRL · 122 source facts · 20 selected values
Validation findings
XBRL valid
- Reporting period
- 2023-04-01 to 2024-03-31
- Extraction status
- complete
- Numeric facts
- 80
- Documents processed
- 1
- XBRL standards validation
- valid
- Filing-profile validation
- invalid
- Parser
- arelle 2.44.4
- Taxonomy
- FRS-102-2023-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_2503_07966622_20240331
- Source archive
- Accounts_Monthly_Data-March2025.zip
Extraction findings: filing rules invalid. These describe source processing, not an audit opinion on the company.
Accounts to 2023-03-31
IXBRL · 127 source facts · 22 selected values
Not assessedlegacy record
Accounts to 2023-03-31
IXBRL · 127 source facts · 22 selected values
Not assessed
legacy record
- Reporting period
- 2022-04-01 to 2023-03-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 84
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2023-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_1866_07966622_20230331
- Source archive
- Accounts_Monthly_Data-March2024.zip
Accounts to 2022-03-31
IXBRL · 147 source facts · 22 selected values
Not assessedlegacy record
Accounts to 2022-03-31
IXBRL · 147 source facts · 22 selected values
Not assessed
legacy record
- Reporting period
- 2021-04-01 to 2022-03-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 90
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2019-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0009_07966622_20220331
- Source archive
- Accounts_Monthly_Data-March2023.zip
Accounts to 2021-03-31
IXBRL · 145 source facts · 22 selected values
Not assessedlegacy record
Accounts to 2021-03-31
IXBRL · 145 source facts · 22 selected values
Not assessed
legacy record
- Reporting period
- 2020-04-01 to 2021-03-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 88
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2019-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0099_07966622_20210331
- Source archive
- Accounts_Monthly_Data-December2021.zip
Accounts to 2020-03-31
IXBRL · 145 source facts · 22 selected values
Not assessedlegacy record
Accounts to 2020-03-31
IXBRL · 145 source facts · 22 selected values
Not assessed
legacy record
- Reporting period
- 2019-04-01 to 2020-03-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 88
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2019-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0088_07966622_20200331
- Source archive
- Accounts_Monthly_Data-March2021.zip
Accounts to 2019-03-31
IXBRL · 158 source facts · 22 selected values
Not assessedlegacy record
Accounts to 2019-03-31
IXBRL · 158 source facts · 22 selected values
Not assessed
legacy record
- Reporting period
- 2018-04-01 to 2019-03-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 83
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2014-09-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0068_07966622_20190331
- Source archive
- Accounts_Monthly_Data-July2019.zip
Accounts to 2018-03-31
IXBRL · 162 source facts · 22 selected values
Not assessedlegacy record
Accounts to 2018-03-31
IXBRL · 162 source facts · 22 selected values
Not assessed
legacy record
- Reporting period
- 2017-04-01 to 2018-03-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 88
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2014-09-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0058_07966622_20180331
- Source archive
- Accounts_Monthly_Data-September2018.zip
Accounts to 2017-03-31
IXBRL · 135 source facts · 22 selected values
Not assessedlegacy record
Accounts to 2017-03-31
IXBRL · 135 source facts · 22 selected values
Not assessed
legacy record
- Reporting period
- 2016-04-01 to 2017-03-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 83
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2014-09-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0049_07966622_20170331
- Source archive
- Accounts_Monthly_Data-December2017.zip
Accounts to 2016-03-31
IXBRL · 75 source facts · 22 selected values
Not assessedlegacy record
Accounts to 2016-03-31
IXBRL · 75 source facts · 22 selected values
Not assessed
legacy record
- Reporting period
- 2015-04-01 to 2016-03-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 54
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- uk-gaap-full-2009-09-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0037_07966622_20160331
- Source archive
- Accounts_Monthly_Data-December2016.zip
Accounts to 2014-03-31
IXBRL · 77 source facts · 22 selected values
Not assessedlegacy record
Accounts to 2014-03-31
IXBRL · 77 source facts · 22 selected values
Not assessed
legacy record
- Reporting period
- 2013-04-01 to 2014-03-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 43
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- uk-gaap-full-2009-09-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0012_07966622_20140331
- Source archive
- Accounts_Monthly_Data-November2014.zip
Accounts to 2013-03-31
IXBRL · 53 source facts · 7 selected values
Not assessedlegacy record
Accounts to 2013-03-31
IXBRL · 53 source facts · 7 selected values
Not assessed
legacy record
- Reporting period
- 2012-02-27 to 2013-03-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 20
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- uk-gaap-full-2009-09-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_9997_07966622_20130331
- Source archive
- Accounts_Monthly_Data-December2013.zip
Registered details
07966622- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 2012-02-27
- Jurisdiction
- —
- Registered office
- LONDON BIOSCIENCE INNOVATION CENTRE, 2 ROYAL COLLEGE STREET, LONDON, NW1 0NH
Classification
1 SIC codes23103
Capital & company events
Reconstructed equity rounds and matched research funding.
Equity fundraising
0 SH01-derived roundsNo reconstructed allotment rounds.
Research and innovation
15 matched grantsExploring the Feasibility of Lidocaine:Nanocin™ Antimicrobial Formulation in Treating Recurrent Urinary Tract InfectionsLead
Innovate UK · Feasibility Studies · 2025-09-01 – 2026-08-31
£82,612
awarded
NANOZYME - Endo-metritis therapy for dairy cows – combining tissue release and infection controlLeadLive
Innovate UK · Collaborative R&D · 2024-07-01 – 2027-06-30
£275,386
awarded
Novel AMD Treatment via Topical Nanocin Delivery of Anti-VEGFLead
Innovate UK · Collaborative R&D · 2024-07-01 – 2025-06-30
£80,654
awarded
Scalable AAV production in high density suspension HEK293SF-3F6 cell culture using Nanocin transfectionLead
Innovate UK · Collaborative R&D · 2021-05-01 – 2023-01-31
£95,816
awarded
Development of a coupled inactivating transport medium and RNA purification protocol for SARS-CoV-2Innovate UK · Collaborative R&D · 2020-08-01 – 2021-09-30 · with 1 other participant£33,626awarded
Development of a coupled inactivating transport medium and RNA purification protocol for SARS-CoV-2
Innovate UK · Collaborative R&D · 2020-08-01 – 2021-09-30 · with 1 other participant
£33,626
awarded
Tecrea Limited£33,626
Improving ophthalmic drug delivery by novel formulations: peptidic hydrogels and nanoparticlesInnovate UK · Feasibility Studies · 2018-05-01 – 2019-04-30 · with 1 other participant£28,020awarded
Improving ophthalmic drug delivery by novel formulations: peptidic hydrogels and nanoparticles
Innovate UK · Feasibility Studies · 2018-05-01 – 2019-04-30 · with 1 other participant
£28,020
awarded
Tecrea Limited£28,020
National Biofilms Innovation CentreBBSRC · Research Grant · 2017-12-01 – 2022-11-30 · with 259 other participants£12,801,513whole project
National Biofilms Innovation Centre
BBSRC · Research Grant · 2017-12-01 – 2022-11-30 · with 259 other participants
£12,801,513
whole project
University of Southamptonlead3M5D Health Protection Group LtdAarhus UniversityAberystwyth UniversityAccelerated MaterialsAdaptavateAdtec Plasma TechnologyAkzoNobelAlderley ParkAlgiPharmaAlphasonicsAltered Carbon Ltd.Anacail LtdAqualution Systems LtdArgent EnergyArgentine Chamber of BioinputsARM LimitedAston UniversityAstrazenecaBAM Federal Institute for Materials Research and TestingBarts Health NHS TrustBear Valley Ventures LtdBelfry TherapeuticsBiacconBioInteractionsBiotechnology and Biological Sciences Research Council (BBSRC)Birmingham City UniversityBlueberry TherapeuticsBluTest Laboratories LimitedBP (British Petroleum)BritestBritish Fashion CouncilBritish Geological SurveyBrunel University LondonCairn Research LtdCanterbury Christ Church UniversityCardiff UniversityCC BiotechCeramisysChelsea Technologies GroupChilled Food AssociationCICA Biomedical LtdColumbia UniversityCommonwealth Scientific and Industrial Research OrganisationCranfield UniversityCreo Medical LtdCroda InternationalCromerix LtdCyanofeed LtdCystic Fibrosis FoundationCystic Fibrosis TrustCytaCoatDefence Science & Technology Laboratory (DSTL)Delft University of Technology (TU Delft)De Montfort UniversityDestiny PharmaDiamond Coatings LimitedDnv GlDurham UniversityEarlham InstituteEberhard Karls University of TübingenEdinburgh BioquarterEdinburgh Napier UniversityEmerson & Renwick LimitedEngineering and Physical Sciences Research Council (EPSRC)Environmental Monitoring Solutions LtdESP TechnologyEuropean Circuits LimitedExtronics LtdFaraPack PolymersFerring PharmaceuticalsFixed phage limitedFourth State Medicine LtdFrontier IP Group plcFujifilmGencoaGenesis BiosciencesGeorgia Institute of TechnologyGlasgow Caledonian UniversityGlaxoSmithKline (GSK)Go South Coast LtdGovernment of BangladeshGovernment of Saudi ArabiaHarman TechnologyHealth and Safety Executive (HSE)Heriot-Watt UniversityHigh Value Manufacturing CatapultHistoric EnglandIbioicImperial College LondonInnovate UKIntelligent Imaging Innovations LtdIo-CyteIsle of Wight CouncilJames Hutton InstituteJiangxi Normal UniversityJNCASR Jawaharlal Nehru Centre for Advanced Scientific ResearchJohns Hopkins UniversityKarlsruhe Institute of TechnologyKarolinska InstituteKeele UniversityKimalKing's College HospitalKing'S College LondonKnowledge Economy Skills Scholarships (KESS)Kohler Mira LTDLaboratory of the Government Chemist (LGC) LtdLancaster UniversityLgc LtdLiverpool Heart And Chest HospitalLiverpool John Moores UniversityLiverpool School of Tropical MedicineLoughborough UniversityMagnitude BiosciencesMakerere UniversityManchester Metropolitan UniversityManchester University NHS Foundation TrustMatoke HoldingsMedical Research Council (MRC)Medicines Discovery CatapultMedipure LtdMicreosMid Yorkshire Hospitals NHS TrustMondelez InternationalMontana State UniversityM Squared Lasers LtdMuseum of Science and Industry (MOSI)NanoVibronix IncNanyang Technological UniversityNational Biofilms Innovation CentreNational Center for Scientific Research (Centre National de la Recherche Scientifique CNRS)National Institute for Health and Care ResearchNational Institute of Agricultural TechnologyNational metrology and testing laboratoryNational Physical LaboratoryNational Scientific and Technical Research Council (Argentina)National University of Río CuartoNational University of RosarioNeem BiotechNeotherix LtdNewcastle UniversityNIHR Southampton Biomedical Research CentreNorthumbrian WaterNottingham Trent UniversityNovaBiotics Ltd, UKNova SANovonesisOsteoCare Implant System LtdOxford NanoImagingOxi-Tech Solutions LtdPENTAX Medical CompanyPerfectus Biomed Ltd.PerlemaxPilkington GlassPlantworks Ltd UKPlantwork Systems (PWS) LtdPlymouth Marine LaboratoryPolytechnic University of ValenciaPrinceton UniversityProcter & GamblePublic Health EnglandPukka Herbs LtdQuadram Institute BioscienceQueen Mary University of LondonQueen's University BelfastRegional Centre for BiotechnologyReta Lila Weston Trust For Medical ResearchRosetrees TrustSalford Royal NHS Foundation TrustSASTRA UniversitySavitribai Phule Pune UniversityScience and Technologies Facilities Council (STFC)Scotland's Rural CollegeScottish Universities Life Sciences AllianceScottish WaterSeaweed and CoSellafield LtdSETsquared PartnershipSheffield Hallam UniversityShell Global Solutions International BVShimyaTech LtdSingapore Centre for Environmental Life Sciences EngineeringSmith and NephewSmiths MedicalStavanger University HospitalSteam-e Holdings LimitedSwansea UniversitySyngenta International AGSystagenix Wound Management ManufacturingTata Steel EuropeTechnical University of DenmarkTechnovent LtdTecrea LtdT-Edta LtdTeesside UniversityTeleflex MedicalTripura UniversityUK Health Security AgencyUltrawave LtdUnileverUnited Kingdom Research and InnovationUniversity College LondonUniversity Hospitals Bristol NHS Foundation TrustUniversity Hospital Southampton NHS Foundation TrustUniversity of AberdeenUniversity of BathUniversity Of BirminghamUniversity of BradfordUniversity of BristolUniversity of CambridgeUniversity of DundeeUniversity Of East AngliaUniversity Of EdinburghUniversity of EssexUniversity of ExeterUniversity of GhanaUniversity of GhentUniversity of GlasgowUniversity of HelsinkiUniversity of HertfordshireUniversity of HuddersfieldUniversity of HullUniversity of KentUniversity of La PlataUniversity of LavalUniversity of LeedsUniversity of LincolnUniversity of LiverpoolUniversity Of ManchesterUniversity of NavarraUniversity Of NewcastleUniversity Of NottinghamUniversity Of OxfordUniversity of PortoUniversity of PortsmouthUniversity of SheffieldUniversity of St AndrewsUniversity of StrathclydeUniversity of SurreyUniversity Of SussexUniversity Of The Highlands And IslandsUniversity of the West of EnglandUniversity of WarwickUniversity Of YorkUpperton Pharma SolutionsValeportVaricon Aqua Solutions LtdVeolia Environmental ServicesVeolia Environmental TrustVeolia Water TechnologiesVictoria and Albert MuseumVirustatic LtdVirustatic Shield LtdVitacress Salads LtdWellcome TrustWelsh WaterWelsh Wound Innovation CentreYeo Marketing LimitedYouSeq Ltd
Track and measure polymeric nanoparticlesLeadInnovate UK · Collaborative R&D · 2017-06-01 – 2018-03-31 · with 1 other participant£25,000awarded
Track and measure polymeric nanoparticlesLead
Innovate UK · Collaborative R&D · 2017-06-01 – 2018-03-31 · with 1 other participant
£25,000
awarded
Tecrea Limitedlead£25,000
Scalable AAV Production using Novel Hollow Fibre BioreactorsLeadInnovate UK · Feasibility Studies · 2015-05-01 – 2016-07-31 · with 1 other participant£36,144awarded
Scalable AAV Production using Novel Hollow Fibre BioreactorsLead
Innovate UK · Feasibility Studies · 2015-05-01 – 2016-07-31 · with 1 other participant
£36,144
awarded
Tecrea Limitedlead£36,144
Modulating intracellular oncology targets using Adhirons™ – a novel therapeutic approachLeadInnovate UK · Feasibility Studies · 2014-08-01 – 2015-07-31 · with 1 other participant£74,795awarded
Modulating intracellular oncology targets using Adhirons™ – a novel therapeutic approachLead
Innovate UK · Feasibility Studies · 2014-08-01 – 2015-07-31 · with 1 other participant
£74,795
awarded
Tecrea Limitedlead£74,795
Formulation for targeted delivery of novel therapies for oncologyInnovate UK · Collaborative R&D · 2014-05-01 – 2019-03-31 · with 2 other participants£250,653awarded
Formulation for targeted delivery of novel therapies for oncology
Innovate UK · Collaborative R&D · 2014-05-01 – 2019-03-31 · with 2 other participants
£250,653
awarded
Formulation of messenger RNA for Intracellular Delivery and ExpressionLead
Innovate UK · Feasibility Studies · 2013-08-01 – 2013-11-30
£24,600
awarded
Formulation and stability of biological products for skin delivery focussing on Retinol.Innovate UK · Feasibility Studies · 2013-08-01 – 2013-11-30 · with 1 other participant£10,875awarded
Formulation and stability of biological products for skin delivery focussing on Retinol.
Innovate UK · Feasibility Studies · 2013-08-01 – 2013-11-30 · with 1 other participant
£10,875
awarded
Tecrea Limited£10,875
IP protection of Nanocin for Infectious Disease TherapyLead
Innovate UK · Vouchers · 2012-11-01 – 2013-03-31
£5,000
awarded
Non-toxic Platform for Biomolecule Delivery into CellsLead
Innovate UK · Feasibility Studies · 2012-08-01 – 2012-11-30
£23,850
awarded